Activating transcription factor 3 is a potential target and a new biomarker for the prognosis of atherosclerosis
- PDF / 9,880,522 Bytes
- 11 Pages / 595.276 x 790.866 pts Page_size
- 52 Downloads / 179 Views
RESEARCH ARTICLE
Activating transcription factor 3 is a potential target and a new biomarker for the prognosis of atherosclerosis Weiwei Qin1 · Huiyu Yang1 · Gaizhen Liu1 · Rui bai1 · Yunfei Bian1 · Zhiming Yang1 · Chuanshi Xiao1,2 Received: 12 April 2020 / Accepted: 10 September 2020 © Japan Human Cell Society 2020
Abstract ATF3 (activating transcription factor 3) is a member of the mammalian activation transcription factor/cAMP-responsive element-binding (CREB) family. It plays a role in inflammation and innate immunity, and suggests that ATF3 is associated with atherosclerosis. In our study, we analyzed datasets of atherosclerosis from the NCBI-GEO (Gene Expression Omnibus) database and found that expression levels of ATF3 were lower in macrophages from ruptured atherosclerotic plaques than from stable atherosclerotic plaques. Expression levels of ATF3 correlated with the stability of atherosclerotic plaques. KEGG analysis of different expression genes (DEGs) between ruptured and stable atherosclerotic plaques was performed by Metascape database. The PI3K-AKT pathway may be a potential pathway of the formation of ruptured atherosclerotic plaques. High-fat diet-induced atherosclerosis a poE−/− mice were divided into two groups: a model group and an ATF3 overexpression (OE)-group. Tests on atherosclerotic plaques in the aortic root suggested that absence of ATF3 and increase of macrophages may be risk factors for the formation of ruptured atherosclerotic plaques. We found decreased areas of lesions in aortic roots and branches of aortic arch, as well as increased lesional content of macrophages as well as TUNEL-positive areas. Consistent with these results, we found reduced degradation and incidence of elastic plate cracks accompanied by suppressed MMPs expression and transduction pathway protein PI3K/AKT activation. These data suggest that ATF3 is a signaling molecule that mediates the progression and stability of atherosclerotic plaques. ATF3 could be a potential new biomarker for the prognosis of atherosclerosis and may be a therapeutic target to reduce atherosclerosis. Keywords Atherosclerosis · ATF3 · Macrophage · Bioinformatics analysis · PI3K-AKT pathway
Introduction ATF3 (activating transcription factor 3) is a member of the mammalian activating transcription factor and the cAMPresponsive element-binding protein (ATF/CREB) family of transcription factors. It has been reported that ATF3 is translated by an immediate early gene and its expression is weak in various cells; however, it can be induced in a variety of stressed tissues, including atherosclerotic plaques, blood-deprived heart tissue and injured peripheral nerves * Chuanshi Xiao [email protected] 1
Department of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, People’s Republic of China
Department of Cardiology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Taiyuan 030001, Shanxi, People’s Republic of China
2
[1]. ATF3 is a critical transcriptional regulator that
Data Loading...
